Drugs Made In America Acquisition Corp. - Rights (NQ:DMAAR)
0.1370
+0.0320
(+30.48%)
Streaming Delayed Price
Updated: 3:53 PM EDT, May 6, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,514,469 |
| Open | 0.1350 |
| Bid (Size) | 0.1260 (500) |
| Ask (Size) | 0.1590 (1,000) |
| Prev. Close | 0.1050 |
| Today's Range | 0.1260 - 0.1400 |
| 52wk Range | 0.0400 - 0.2433 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Wednesday's session: gap up and gap down stocks ↗
Today 10:30 EDT
These stocks are moving in today's pre-market session ↗
Today 8:30 EDT
Performance
More News
Read More
Wednesday's session: gap up and gap down stocks ↗
April 15, 2026
Wednesday's session: gap up and gap down stocks ↗
April 08, 2026
Tuesday's session: top gainers and losers ↗
September 16, 2025
Let's take a look at the stocks that are in motion in today's session. ↗
September 16, 2025
Frequently Asked Questions
Is Drugs Made In America Acquisition Corp. - Rights publicly traded?
Yes, Drugs Made In America Acquisition Corp. - Rights is publicly traded.
What exchange does Drugs Made In America Acquisition Corp. - Rights trade on?
Drugs Made In America Acquisition Corp. - Rights trades on the Nasdaq Stock Market
What is the ticker symbol for Drugs Made In America Acquisition Corp. - Rights?
The ticker symbol for Drugs Made In America Acquisition Corp. - Rights is DMAAR on the Nasdaq Stock Market
What is the current price of Drugs Made In America Acquisition Corp. - Rights?
The current price of Drugs Made In America Acquisition Corp. - Rights is 0.1370
When was Drugs Made In America Acquisition Corp. - Rights last traded?
The last trade of Drugs Made In America Acquisition Corp. - Rights was at 05/06/26 03:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.